Table 6. Comparison of the mean CMT between each group and baseline values.

CMT (µm)	Baseline evaluation	Following evaluation visit	P	Effect size, r
Naïve patients
Baseline-2wk (n=10)	478.00±134.27	411.60±101.31	0.008	0.789
Baseline-Month 1 (n=12)	540.83±145.604	419.08±130.44	0.002	0.779
Baseline-Month 2 (n=25)	522.24±117.355	348.88±70.30	0.000	0.764
Baseline-Month 3 (n=11)	523.18±110.793	390.82±132.67	0.016	0.524
Baseline-Month 4 (n=22)	529.50±124.683	429.86±128.17	0.001	0.464
Baseline-Month 6 (n=18)	464.44±75.010	408.06±109.17	0.017	0.571
Non-naïve patients
Baseline-2wk (n=4)	803.00±308.299	681.00±325.27	--a	--
Baseline-Month 1 (n=3)	693.33±289.144	482.00±345.88	--a	--
Baseline-Month 2 (n=9)	500.67±145.128	346.00±142.20	0.008	0.454
Baseline-Month 3 (n=6)	481.83±268.024	408.17±269.18	0.043	0.973
Baseline-Month 4 (n=14)	453.71±126.508	381.43±142.97	0.016	0.183
Baseline-Month 6 (n=9)	425.22±87.102	378.33±111.29	0.139	0.243

CMT: Central macular thickness; SD: Standard deviation. ^aNo comparison was performed for these 2 groups due to low number of patients.

mean±SD